Tyrosine Kinase Inhibitor (TKI) Switching Patterns during the First 12 Months in Simplicity, an Observational Study of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients (Pts) in Routine Clinical Practice

Goldberg Stuart; Michallet Mauricette; Hehlmann Rudiger; Zyczynski Teresa; Foreman Aimee; Calimlim Brian; Paquette Ron; Simonsson Bengt; Gambacorti Carlo; Cortes Jorge E.; Zagorska Aleksandra; Rong Yuanxin; Mauro Michael J.

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Tyrosine Kinase Inhibitor (TKI) Switching Patterns during the First 12 Months in Simplicity, an Observational Study of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients (Pts) in Routine Clinical Practice

【24h】

Tyrosine Kinase Inhibitor (TKI) Switching Patterns during the First 12 Months in Simplicity, an Observational Study of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients (Pts) in Routine Clinical Practice

机译：酪氨酸激酶抑制剂（TKI）在常规临床实践中，在前12个月内为前12个月内切换模式，慢性相慢性骨髓白血病（CP-CML）患者（CP-CML）患者（PTS）的观察研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2016年第22期|共5页
作者
Goldberg Stuart; Michallet Mauricette; Hehlmann Rudiger; Zyczynski Teresa; Foreman Aimee; Calimlim Brian; Paquette Ron; Simonsson Bengt; Gambacorti Carlo; Cortes Jorge E.; Zagorska Aleksandra; Rong Yuanxin; Mauro Michael J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Tyrosine Kinase Inhibitor (TKI) Switching Patterns during the First 12 Months in Simplicity, an Observational Study of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients (Pts) in Routine Clinical Practice [J] . Goldberg Stuart, Michallet Mauricette, Hehlmann Rudiger, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：酪氨酸激酶抑制剂（TKI）在常规临床实践中，在前12个月内为前12个月内切换模式，慢性相慢性骨髓白血病（CP-CML）患者（CP-CML）患者（PTS）的观察研究
2. Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic-phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY [J] . Hehlmann Ruediger, Cortes Jorge E., Zyczynski Teresa, American Journal of Hematology . 2019,第1期

机译：常规临床实践中慢性相慢性骨髓白血病患者的酪氨酸激酶抑制剂中断，中断和切换：简单
3. Cardiovascular Hospitalization in Patients Treated with Dasatinib or Nilotinib in Simplicity, an Observational Study of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients in Routine Clinical Practice [J] . Mauro Michael J., Chen Clara, Cortes Jorge E., Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：用达斯替尼或尼洛涅布治疗的患者心血管住院，简化，慢性相慢性骨髓白血病（CP-CML）常规临床实践中的观察研究
4. Novel Inhibitors of T315I Mutant BCR-ABL1 Tyrosine Kinase for Chronic Myeloid Leukemia Disease Through Fragment-Based Drug Design [C] . Satya Anindita, Atika Marnolia, Hersal Hermana Putra, International symposium on bioinformatics research and applications . 2018

机译：T315I突变BCR-ABL1酪氨酸激酶的新型抑制剂通过基于片段的药物设计治疗慢性粒细胞白血病
5. Exploring Clinical and Genetic Factors to Optimize the Use of Tyrosine Kinase Inhibitors in Clinical Practice. [D] . Gillis, Nancy K. 2017

机译：探索临床和遗传因素，以优化酪氨酸激酶抑制剂在临床实践中的使用。
6. Tyrosine kinase inhibitor interruptions discontinuations and switching in patients with chronic‐phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY [O] . Rüdiger Hehlmann, Jorge E. Cortes, Teresa Zyczynski, -1

机译：常规临床实践中的慢性阶段性慢性粒细胞白血病患者酪氨酸激酶抑制剂的中断停药和转换：简单
7. Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice [O] . Carmen Fava, Giovanna Rege-Cambrin, Irene Dogliotti, 2019

机译：慢性髓性白血病意大利患者在临床实践中停止酪氨酸激酶抑制剂的意大利患者的观察研究

Tyrosine Kinase Inhibitor (TKI) Switching Patterns during the First 12 Months in Simplicity, an Observational Study of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients (Pts) in Routine Clinical Practice

著录项

相似文献

相关主题

期刊订阅